Download Citation
Article Source:
Safety and Immunogenicity of rSh28GST Antigen in Humans: Phase 1 Randomized Clinical Study of a Vaccine Candidate against Urinary Schistosomiasis
Riveau G,
Deplanque D,
Remoué F,
Schacht AM,
Vodougnon H,
et al.
(2012)
Safety and Immunogenicity of rSh28GST Antigen in Humans: Phase 1 Randomized Clinical Study of a Vaccine Candidate against Urinary Schistosomiasis.
PLOS Neglected Tropical Diseases 6(7): e1704.
https://doi.org/10.1371/journal.pntd.0001704